The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major

European Journal of Immunology

Volumn 40, Issue 6, 2010, Pages 1697-1707

  Revaz Breton, Mélanie ^a,b,c   Ronet, Catherine ^a,b   Ives, Annette ^b   Hauyon La Torre, Yazmin ^a,b   Masina, Slavica ^b   Tacchini Cottier, Fabienne ^a,b   Launois, Pascal ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cell differentiation; Cytokines; MyD88; Parasitic protozoan

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIA MAJOR IR75; LEISHMANIA MAJOR LV39; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 77953296406     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939821     Document Type: Article

References (32)

1. Reiner, S. L. and Locksley, R. M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
2. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987-995.
3. Kaisho, T. and Akira, S., Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 2001. 22: 78-83.
4. Muller, I., Fruth, U. and Louis, J. A., Immunobiology of experimental leishmaniasis. Med. Microbiol. Immunol. 1992. 181: 1-12.
5. Muraille, E., De Trez, C., Brait, M., De Baetselier, P., Leo, O. and Carlier, Y., Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 2003. 170: 4237-4241. (Pubitemid 36428190)
6. de Veer, M. J., Curtis, J. M., Baldwin, T. M., DiDonato, J. A., Sexton, A., McConville, M. J., Handman, E. and Schofield, L., MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor-2 signaling. Eur. J. Immunol. 2003. 33: 2822-2831.
7. Debus, A., Glasner, J., Rollinghoff, M. and Gessner, A., High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect. Immun. 2003. 71: 7215-7218.
8. Chomarat, P. and Banchereau, J., Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 1998. 17: 1-52.
9. Matthews, D. J., Emson, C. L., McKenzie, G. J., Jolin, H. E., Blackwell, J. M. and McKenzie, A. N., IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 2000. 164: 1458-1462. (Pubitemid 30067261)
10. Noben-Trauth, N., Lira, R., Nagase, H., Paul, W. E. and Sacks, D. L., The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J. Immunol. 2003. 170: 5152-5158. (Pubitemid 36554747)
11. Belkaid, Y., Blank, R. B. and Suffia, I., Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 2006. 212: 287-300.
12. Suffia, I., Reckling, S. K., Salay, G. and Belkaid, Y., A role for CD103 in the retention of CD4+CD25+Treg and control of Leishmania major infection. J. Immunol. 2005. 174: 5444-5455.
13. Aseffa, A., Gumy, A., Launois, P., MacDonald, H. R., Louis, J. A. and Tacchini-Cottier, F., The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/cmice are subject to the control of regulatory CD4+CD25+T cells. J. Immunol. 2002. 169: 3232-3241. (Pubitemid 35013170)
14. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S. and Locksley, R. M., Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 1990. 171: 115-127.
15. Noben-Trauth, N., Paul, W. E. and Sacks, D. L., IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 1999. 162: 6132-6140. (Pubitemid 29314974)
16. Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K. and Akira, S., Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 2001. 166: 5688-5694. (Pubitemid 32374193)
17. Pasare, C. and Medzhitov, R., Toll pathway-dependent blockade of CD4+ CD25+T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
18. Satoskar, A. R., Okano, M., Connaughton, S., Raisanen-Sokolwski, A., David, J. R. and Labow, M., Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 1998. 28: 2066-2074.
19. Monteforte, G. M., Takeda, K., Rodriguez-Sosa, M., Akira, S., David, J. R. and Satoskar, A. R., Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J. Immunol. 2000. 164: 5890-5893. (Pubitemid 30389835)
20. Kostka, S. L., Knop, J., Konur, A., Udey, M. C. and von Stebut, E., Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections. J. Invest. Dermatol. 2006. 126: 1582-1589.
21. Sun, D. and Ding, A., MyD88-mediated stabilization of interferongamma-induced cytokine and chemokine mRNA. Nat. Immunol. 2006. 7: 375-381.
22. Kang, S. J., Liang, H. E., Reizis, B. and Locksley, R. M., Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity 2008. 29: 819-833.
23. Kropf, P., Freudenberg, M. A., Modolell, M., Price, H. P., Herath, S., Antoniazi, S., Galanos, C. et al., Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 2004. 72: 1920-1928.
24. Becker, I., Salaiza, N., Aguirre, M., Delgado, J., Carrillo-Carrasco, N., Kobeh, L. G., Ruiz, A. et al., Leishmania lipophosphoglycan activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 2003. 130: 65-74.
25. Liese, J., Schleicher, U. and Bogdan, C., TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 2007. 37: 3424-3434.
26. Hkima Abou Fakher, F., Rachinel, N., Klimczak, M., Louis, J. and Doyen, N., TLR9-Dependent Activation of Dendritic Cells by DNA from Leishmania major Favors Th1 Cell Development and the Resolution of Lesions. J. Immunol. 2009. 182: 1386-1396.
27. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H. and Heeg, K., CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 1998. 160: 3627-3630. (Pubitemid 28176060)
28. Abou Fakher, F. H., Rachinel, N., Klimczak, M., Louis, J. and Doyen, N., TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J. Immunol. 2009. 182: 1386-1396.
29. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S., Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998. 9: 143-150.
30. Louis, J., Moedder, E., Behin, R. and Engers, H., Recognition of protozoan parasite antigens by murine T lymphocytes. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica. Eur. J. Immunol. 1979. 9: 841-847.
31. Launois, P., Swihart, K. G., Milon, G. and Louis, J. A., Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 1997. 158: 3317-3324. (Pubitemid 127484049)
32. Slade, S. J. and Langhorne, J., Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 1989. 179: 353-365. (Pubitemid 19268311)